Tilray stock soars 10% after company tapped to provide medical cannabis in French study

by Raphael Stevens 26 January 2021, 15:18 199 Views

Tilray’s products will treat patients with neuropathic pain, epilepsy and multiple sclerosis who aren’t getting relief from existing treatments.

Source: Business - cnbc.com

Cramer: 'Astounding numbers' at struggling GE, Raytheon may justify stock market's rally

Cici's files for bankruptcy as pandemic accelerates the decline of the all-you-can-eat buffet

This portal is not a newspaper as it is updated without periodicity. It cannot be considered an editorial product pursuant to law n. 62 of 7.03.2001. The author of the portal is not responsible for the content of comments to posts, the content of the linked sites. Some texts or images included in this portal are taken from the internet and, therefore, considered to be in the public domain; if their publication is violated, the copyright will be promptly communicated via e-mail. They will be immediately removed.

Tilray stock soars 10% after company tapped to provide medical cannabis in French study

Cramer: 'Astounding numbers' at struggling GE, Raytheon may justify stock market's rally

Cici's files for bankruptcy as pandemic accelerates the decline of the all-you-can-eat buffet

ITALIAN LANGUAGE

ENGLISH LANGUAGE